Trevena Announces Results of TRV027 Proof-of-Concept Study in COVID-19 Patients Sep 30, 2021 7:00am EDT
Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences & MedTech Summit Sep 17, 2021 7:00am EDT
Trevena to Present at the H.C. Wainwright 23rd Annual Global Investment Conference Sep 09, 2021 7:00am EDT
Trevena Announces Two OLINVYK® Abstracts Highlighting Safety Data Accepted at ANESTHESIOLOGY® 2021 Aug 30, 2021 7:00am EDT
Trevena Announces Wake Forest Baptist Health Joining OLINVYK® Clinical Outcomes Study Aug 25, 2021 7:00am EDT
Trevena Announces Publication Highlighting Risk / Benefit Analysis of OLINVYK® in Pain and Therapy Aug 10, 2021 7:00am EDT
Trevena to Release Second Quarter 2021 Financial Results on August 12th, 2021 Aug 09, 2021 7:00am EDT
Trevena Announces First Patient Enrolled in NIH-Funded ACTIV-4 Host Tissue Trial of TRV027 for COVID-19 Jul 26, 2021 7:00am EDT
